| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
5-Methoxy cytidine manufacturers
- 5-Methoxy cytidine
-
-
2026-08-13
- CAS:37805-90-6
- Min. Order: 1G
- Purity: 97%
- Supply Ability: 2000
|
| | 5-Methoxy cytidine Basic information |
| Product Name: | 5-Methoxy cytidine | | Synonyms: | 5-Methoxy cytidine;4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methoxypyrimidin-2-one;Cytidine, 5-methoxy-;5-OMe-Cr;4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidin-2(1H)-one | | CAS: | 37805-90-6 | | MF: | C10H15N3O6 | | MW: | 273.24 | | EINECS: | | | Product Categories: | | | Mol File: | 37805-90-6.mol |  |
| | 5-Methoxy cytidine Chemical Properties |
| Boiling point | 569.9±60.0 °C(Predicted) | | density | 1.81±0.1 g/cm3(Predicted) | | pka | 13.48±0.70(Predicted) |
| | 5-Methoxy cytidine Usage And Synthesis |
| Uses | 5-Methoxy cytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. | | References | [1] Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8. DOI:10.4161/cbt.3.11.1308 |
| | 5-Methoxy cytidine Preparation Products And Raw materials |
|